Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME ...

According to Research by SNS Insider, Point-of-Care Diagnostics Market Growth is Fueled by Technological Advancements and Rising Prevalence of Chronic DiseasesPune, March 21, 2025 (GLOBE NEWSWIRE) -- ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this. Whatever happens, though ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands ...

Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can't produce enough insulin.

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Key Takeaways Continuous glucose monitors can improve traffic safety among people with diabetesPeople had fewer incidents of hypoglycemia behind the wheel when monitors provided real-time blood sugar ...

The Abbott Lingo CGM is a different kind of meal tracker, and I recommend it to anyone who's bio-wearable-curious. Here's why.